There are now more than 200 independent medical imaging AI software vendors, with 73% of the funds concentrated among the top 25. 

Also, lung cancer-focused Leadoptik scores $5M in seed financing, Hyperfine earns $3M grant to extend research, and Intelerad supports new AAWR-RadEqual partnership. 

The Israel-headquartered firm specializes in AI-based ultrasound image examination, scoring its ninth U.S. FDA clearance in February. 

However, GPT-4 confidently delivered incorrect or irrelevant answers on some questions, according to new research in Radiology. 

A new paper details how a team at the University of California utilized a hybrid system consisting of a quality coordinator and NLP software to bring in more than $60,000 in additional revenue from follow-up imaging alone.

Cardiology is linked to the second largest group of FDA-cleared clinical AI algorithms, and the number is still growing. 

Marcelo DiCarli, MD, and Rob Beanlands, MD, discussed the long-term value of investing in the development and implementation of AI technologies. 

PET/CT saw the biggest gains, up almost 21% year-over-year compared to Q1 of 2022, with the group collecting $390M in revenue (up 14%).